Valgen Medtech
Hangzhou
About Valgen Medtech
Valgen focus on treatment technologies and systemic solutions for heart disease, especially for mitral and tricuspid valve lesions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $188.0M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2021)
- Website: valgenmed.com
Industries & Categories
Health Care, Health Diagnostics, Hospital
Canonical: https://fsome.com/organization/valgen-medtech-41400 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.